Blue Goat CyberBlue Goat CyberSMMedical Device Cybersecurity
    K
    Blog · Podcast

    The Hidden Reason MedTech Products Get Recalled (It's Not Quality Issues) with William Jin | Ep. 55

    In this episode of The Med Device Cyber Podcast, hosts Trevor Slatterie and Christian Espinosa, joined by special guest William Jin, delve into the often-overlooked cybersecurity challenges that lead to medical device recalls and hinder market expansion. William Jin, with over 30

    Hero illustration for the Podcast article: The Hidden Reason MedTech Products Get Recalled (It's Not Quality Issues) with William Jin | Ep. 55
    Christian Espinosa, Founder & CEO

    Reviewed by Christian Espinosa, MBA, CISSP · Founder & CEO

    Published January 2026 · Last reviewed May 2026

    The Med Device Cyber Podcast · with William Jin · January 30, 2026 In this episode of The Med Device Cyber Podcast, hosts Trevor Slatterie and Christian Espinosa, joined by special guest William Jin, delve into the often-overlooked cybersecurity challenges that lead to medical device recalls and hinder market expansion. William Jin, with over 30 years in the MedTech industry and experience at companies like Medtronic and Stryker, offers a unique perspective on navigating both the Chinese and US/European markets. The discussion highlights crucial differences in cybersecurity regulations between the NMPA (China) and the FDA (US), emphasizing that NMPA requirements are not just stringent but uniquely divergent, often necessitating two separate product builds for compliance. A significant focus is placed on the impact of early design decisions, such as cloud platform selection (e.g., Google Cloud versus Amazon China), on market viability and the costly ramifications of not considering target markets from the outset. The episode underscores the increasing frequency of cybersecurity-related recalls, exemplified by the Baxter Life 2000 ventilation system, and stresses the critical importance of integrating cybersecurity throughout the entire product lifecycle, from design to disposal, to prevent costly setbacks and ensure product success in a globalized MedTech landscape.

    Key Takeaways

    • Medical device companies must consider target markets like China, the US, and Europe from the initial design phase to avoid costly redesigns and ensure market viability.
    • The NMPA in China has unique and stringent cybersecurity requirements, often necessitating a completely separate product build and regulatory filing compared to FDA requirements.
    • Choosing a cloud platform, such as Google Cloud, without considering its compatibility with specific markets like China, can lead to significant barriers to market entry.
    • Cybersecurity-related medical device recalls are increasing, as evidenced by the Baxter Life 2000 ventilation system recall, highlighting the critical need for proactive cybersecurity measures.
    • Integrating cybersecurity through the entire product lifecycle, from design to disposal, is essential to prevent recalls, ensure regulatory compliance, and safeguard financial resources.
    • Staying informed about evolving cybersecurity regulations and market-specific requirements is crucial for success in the rapidly changing global MedTech industry.
    • Chinese medical device companies face challenges in entering US/European markets due to a lack of cybersecurity awareness and commercial knowledge, in addition to IP concerns.
    • US and European companies face challenges entering the Chinese market due to longer registration times, data exchange restrictions, and the incompatibility of certain platforms like Google Cloud with Chinese regulations.

    Listen on mdcpodcast.com · Watch on YouTube

    Listen to this episode

    Watch on YouTube


    Want help applying this to your own device program?

    Blue Goat Cyber is a specialist medical device cybersecurity firm: 250+ FDA submissions, zero rejections. If anything in this conversation hit close to home, book a 30-minute strategy session - no cost, no obligation.

    Related articles

    Keep reading

    Related services

    Put this into practice on your device

    Every Blue Goat Cyber engagement maps directly to FDA Section 524B and the SPDF - so the evidence you need lands in your submission, not in a separate report.

    Ready when you are

    Get FDA cleared without the cybersecurity headaches.

    30-minute strategy session. No cost, no commitment - just answers from people who've shipped 250+ submissions.